Hoechst Pakistan (HPL) Stock Analysis & Shariah Status

Hoechst Pakistan Limited (PSX: HPL) is a Pakistan Stock Exchange-listed pharmaceutical company engaged in manufacturing, selling and trading pharmaceutical and related products. Incorporated in 1967, the company operates from Korangi Industrial Area, Karachi, and reports its financial results on a calendar-year basis. In FY2025, Hoechst Pakistan reported sales of Rs30.929 billion, profit after tax of Rs2.910 billion and EPS of Rs301.67, compared with sales of Rs26.748 billion and profit after tax of Rs1.857 billion in FY2024. For the quarter ended September 30, 2026, it reported sales of Rs7.790 billion, profit after tax of Rs614.346 million and EPS of Rs63.70. HPL was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published in May 2026, based on December 2025 financial statements. Investors should monitor quarterly profitability, product and regulatory developments, dividend sustainability and any changes in the company's latest Shariah screening status.

Hoechst Pakistan Limited (PSX: HPL) is a Pakistan Stock Exchange-listed pharmaceutical company engaged in the manufacturing, selling and trading of pharmaceutical and related products. The company was incorporated in Pakistan in 1967 as a public limited company and operates in the pharmaceutical sector.

Its business performance is influenced by prescription and consumer healthcare demand, product availability, manufacturing and distribution costs, pricing regulations, product registrations, currency movements and the broader healthcare environment.

Business Overview

Hoechst Pakistan operates in Pakistan's pharmaceutical market, where the ability to maintain product availability, quality standards, regulatory compliance and an effective distribution network is important to business performance.

The company’s registered address is Plot No. 23, Sector 22, Korangi Industrial Area, Karachi, Pakistan. Its financial year ends on December 31.

Investors researching the business should consult its annual and interim financial statements, corporate announcements and official website to understand its current product portfolio, operational developments and financial position.

Official references: Hoechst Pakistan website and PSX company profile.

Financial Performance

For the year ended December 31, 2025, Hoechst Pakistan reported higher sales and profit than in 2024.

Financial Metric	FY2025	FY2024
Sales	Rs30.929 billion	Rs26.748 billion
Profit after tax	Rs2.910 billion	Rs1.857 billion
Earnings per share	Rs301.67	Rs192.56
Gross profit margin	36.53%	31.51%
Net profit margin	9.41%	6.94%

Sales increased by approximately 15.6%, while profit after tax increased by approximately 56.7%. The reported gross and net profit margins also improved year over year.

These results indicate stronger reported profitability in 2025. However, annual growth alone does not establish that the same performance will continue. Investors should review product-level developments where disclosed, production costs, pricing, operating expenses, taxation, cash flow and working capital.

Latest Quarterly Results

For the quarter ended September 30, 2026, the company reported:

Financial Metric	Q3 2026	Q3 2025
Sales	Rs7.790 billion	Rs8.284 billion
Gross profit	Rs2.952 billion	Rs3.047 billion
Operating profit	Rs1.095 billion	Rs1.555 billion
Profit after tax	Rs614.346 million	Rs875.680 million
EPS	Rs63.70	Rs90.79

Quarterly sales declined by approximately 6.0% year over year, while profit after tax declined by approximately 29.8%. Operating profit also decreased, indicating pressure on quarterly profitability compared with the corresponding period of 2025.

These are quarterly, unaudited figures and should not be confused with full-year results. Investors should review the complete interim financial statements to assess the reasons for the changes and whether they are temporary or likely to persist.

Official sources: PSX financials and announcements and Hoechst Pakistan financial reports.

Dividend Information

The board proposed a final cash dividend of Rs190 per share for FY2025 for shareholder approval at the annual general meeting held on April 8, 2026. The company also announced an interim cash dividend of Rs44 per share in 2026, with a dividend-credit notice listed by PSX on September 15, 2026.

The final dividend's approval and payment status should be checked against the AGM resolution and the official payout notice before publication. Proposed, approved and paid dividends are distinct stages and should not be treated as interchangeable.

Dividends are not guaranteed to recur. Future distributions depend on earnings, cash generation, capital requirements and the board's decisions.

Official reference: PSX company announcements and payouts.

Shariah Compliance Status

Hoechst Pakistan Limited was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published on May 29, 2026. The screening was based on financial statements as of December 31, 2025.

The published screening ratios were:

Debt ratio: 1.80%
Non-compliant investment ratio: 9.06%
Non-compliant income ratio: 0.51%
Illiquid assets ratio: 69.87%

The classification reflects the financial information and screening methodology used for that particular review. Shariah status is not permanent and may change following new financial statements, revised ratios or updated screening decisions.

Investors who require Shariah-compliant investments should check the latest official PSX-KMI All Share Islamic Index screening before buying, holding or selling shares.

Official source: PSX-KMI All Share Islamic Index recomposition, May 29, 2026.

Key Factors Investors Should Monitor

Revenue growth: changes in sales and the sustainability of demand.
Profit margins: movements in manufacturing, distribution and operating costs.
Regulatory developments: product registrations, pricing requirements and applicable pharmaceutical standards.
Working capital: inventory, receivables, supplier payments and operating cash flow.
Dividend sustainability: whether cash distributions are supported by earnings and available funds.
Quarterly performance: whether the decline in Q3 2026 sales and profit persists in subsequent reporting periods.
Shariah screening: the latest official classification and ratios.

Frequently Asked Questions

What is Hoechst Pakistan Limited's PSX symbol?

Its Pakistan Stock Exchange symbol is HPL.

Is Hoechst Pakistan Shariah-compliant?

It was classified as Shariah-compliant in the PSX-KMI All Share Islamic Index recomposition published on May 29, 2026, based on December 2025 financial statements. Investors should confirm the latest screening before relying on that classification.

What does Hoechst Pakistan do?

The company manufactures, sells and trades pharmaceutical and related products in Pakistan.

What were its FY2025 results?

For the year ended December 31, 2025, it reported sales of Rs30.929 billion, profit after tax of Rs2.910 billion and EPS of Rs301.67.

What were its Q3 2026 results?

For the quarter ended September 30, 2026, sales were Rs7.790 billion, profit after tax was Rs614.346 million and EPS was Rs63.70.

What dividends has Hoechst Pakistan announced?

A final dividend of Rs190 per share was proposed for FY2025, subject to shareholder approval. A separate interim dividend of Rs44 per share was announced in 2026. Check official resolutions and payout notices for final status.

Official Sources

This profile summarizes publicly available company and exchange information for investor education. Verify the latest financial statements, dividend approvals and payouts, corporate announcements and Shariah screening before making investment decisions.

This profile is for educational purposes and is not a recommendation to buy or sell any security.

Hoechst Pakistan Limited